Cargando…
Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease
PURPOSE: Cholestatic liver diseases are groups of hepatobiliary diseases without curative drug-based therapy options. Regulation of bile acid (BA) metabolism, hepatoperiductal fibrosis, and inflammatory response indicated present novel methods for the treatment of cholestatic liver disease. Costunol...
Autores principales: | Hao, Juan, Shen, Xiaoyu, Lu, Kan, Xu, Yi, Chen, Yiyue, Liu, Jibo, Shao, Xiaohong, Zhu, Chunling, Ding, Yaqin, Xie, Xin, Wu, Jian, Yang, Quanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310871/ https://www.ncbi.nlm.nih.gov/pubmed/37396159 http://dx.doi.org/10.1016/j.jtcme.2023.02.008 |
Ejemplares similares
-
Astragalus saponins and its main constituents ameliorate ductular reaction and liver fibrosis in a mouse model of DDC-induced cholestatic liver disease
por: Zhang, Linzhang, et al.
Publicado: (2022) -
Reversine attenuates cholestatic ductular reaction in rats
por: Huang, Di, et al.
Publicado: (2023) -
Increased microfilaments in hepatocytes and biliary ductular cells in cholestatic liver diseases.
por: Chung, Kyu-Won, et al.
Publicado: (2002) -
BM-MSCs overexpressing the Numb enhance the therapeutic effect on cholestatic liver fibrosis by inhibiting the ductular reaction
por: Xu, Yan-nan, et al.
Publicado: (2023) -
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis
por: Overi, Diletta, et al.
Publicado: (2022)